title: [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
abstract: The materials of observation over 231 patients with highly differentiated thyroid cancer were used to define indications for 131I-therapy, to specify course and summary doses taking into account side-effects of 131I. 131I-therapy is an effective method in multimodality therapy of highly differentiated thyroid cancer.
authors: Z L
authors: ZL
authors: Baranauskas
authors: V V
authors: VV
authors: Mamontov
authors: K K
authors: KK
authors: Valutskas
mesh_terms: D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002291:Carcinoma, Papillary / Q000532:radiotherapy / Q000601:surgery; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D013965:Thyroidectomy
chemical_list: D007457:Iodine Radioisotopes
vernacular_title: Primenenie 131I v kompleksnom lechenii vysokodifferentsirovannogo raka shchitovidnoĭ zhelezy.